Posted on

MediSapiens Supports Bayer’s Future Clinical Trial Program (Updated)

MediSapiens supports Bayer in its Future Clinical Trials program, where Bayer is working to transform clinical trials with data science and patient-centricity. MediSapiens provides its data model knowledge (such as OMOP), data quality capabilities and data management know-how to Bayer, among others.

To hear more, listen to Bayer’s Jussi Leinonen present the Future Clinical Trials program in more detail in the Business Finland Health Tuesday event from 5:30 to 23:30 here  or see Bayer’s press release.